通过Aurora-A介导的Maf1细胞局部化通过调节HCC中线粒体功能的途径促进细胞增殖
Shiang-Jie Yang1,2, Yu-Heng Kuan3, Zong-Xin Ooi3
1The Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan.
Cell death discovery
|December 3, 2025
概括
Maf1是一种RNA聚合酶III的抑制剂,在肝癌 (HCC) 中具有新的致癌作用. 奥罗拉-A酸化Maf1,促进HCC细胞生长,并建议一种新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- Maf1是一种已知的RNA聚合酶III抑制剂和瘤抑制剂.
- 它在肝细胞癌 (HCC) 中的具体作用尚不清楚.
- 这项研究研究了Maf1在HCC中的功能.
研究的目的:
- 为了确定HCC中Maf1的上游调节者.
- 阐明Maf1影响HCC进展的机制.
- 为了探索准 Aurora-A-Maf1 轴的治疗潜力.
主要方法:
- 使用生物化学测试研究了Aurora-A和Maf1之间的相互作用.
- 通过Aurora-A.确定了Maf1的酸化部位.
- 评估了Maf1酸化对HCC细胞行为 (线粒体功能,糖解,增殖) 的影响.
- 与HCC患者的临床结果相关的Maf1和Aurora-A表达.
主要成果:
- 奥罗拉-A直接与Maf1相互作用,并在Threonine-212.12中酸化Maf1.
- 酸化增强了Maf1蛋白的稳定性,并促进了其在细胞质中积累.
- 细胞质Maf1驱动线粒体功能障碍和增加糖分活性,促进HCC细胞的增殖.
- 升高的Maf1表达与HCC的预后不佳相关,特别是高Aurora-A水平.
- 具有高Maf1表达的HCC细胞对奥罗拉-A抑制剂的敏感性增加.
结论:
- Maf1在HCC中发挥着非正规的瘤作用,与其在其他情况下的瘤抑制功能相反.
- 极光-A-Maf1信号通路是HCC进展的关键驱动因素.
- 针对Aurora-A-Maf1轴代表了HCC的潜在治疗策略.
相关概念视频
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:07MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:15M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K